Dec 20, 2024 | by Austin Chelko, Commentary, Value-Based Drug Management
We recently heard of a broker calling on employers with the promise of negotiating higher rebates, and only charging a modest “shared savings” price based on guaranteed increased rebates.
The unfortunate reality is that most buyers and brokers/consultants continue supporting the false narrative of larger rebates equating to a better deal. With rebates growing exponentially (especially in certain classes of drugs), the lure of what seems like a windfall of money is proving increasingly tough to resist for plan sponsors and their advisors. (more…)
Dec 9, 2024 | Commentary
Congratulations. You survived another open enrollment. For many employers, the conclusion of this annual event often feels like crossing the finish line. But in reality, it’s just the starting point of a much longer journey. (more…)
Dec 5, 2024 | Legislative + Regulatory Updates
Employer-sponsored health plans must navigate a crucial period as the federal telehealth coverage safe harbor for High-Deductible Health Plans (HDHPs) nears expiration. This provision, originating in the 2020 CARES Act and extended twice, enables HDHPs to provide pre-deductible (first-dollar) telehealth coverage without jeopardizing Health Savings Account (HSA) eligibility. Unless Congress acts, this relief will sunset on December 31, 2024, impacting plans starting January 1, 2025. (more…)
